• SENSEX 73,377.24
    -229.51 (--0.31%)
  • BANKNIFTY 54,366.70
    79.35 (+0.15%)
  • TVS Holdings
    11,337.15 16,150.00(%)
  • NSE
    1,774.00 1,878.00(%)
  • Ather Energy
    1,702.00 1,741.90(%)
  • Apollo Micro Sys
    446.80 466.70(%)
  • LIC Housing Fin.
    512.00 598.00(%)
  • DLF
    672.55 786.40(%)
  • Persistent Systems
    5,695.50 4,242.65(%)
  • Sona BLW Precis.
    863.90 843.90(%)
  • Adani Enterp.
    2,431.85 1,753.45(%)
  • Federal Bank
    348.20 364.95(%)
  • Reliance Industries
    1,184.00 1,152.30(%)
  • OneSource Speci.
    1,606.35 1,924.00(%)
  • Sky Gold & Diam.
    965.00 1,083.00(%)
  • HDFC Bank
    680.10 682.00(%)
  • SBI Life Insuran
    1,626.75 1,609.20(%)
  • Torrent Pharma.
    4,649.20 5,249.95(%)
  • Tonbo Imaging
    1,300.00 1,331.45(%)
  • Max Healthcare
    857.00 1,196.50(%)
  • GE Vernova T&D
    4,025.00 5,650.00(%)
  • NTPC
    306.70 414.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Abbott India Ltd Pharmaceuticals - Multinational

  • MNC Asc-Abbott
  • BSE Code : 90.0
  • ISIN : INE358A01014
25,225.00 195 (0.78%)
  • As on 27 Oct 2026 (EOD)
  • Today’s Low

    24,805.00
  • Today’s High

    25,365.00
  • Open

    25,235.00
  • Perv Close

    25,030.00
  • 52W Low

    24,650.00
  • 52W High

    30,655.00

Key Indicators

  • P/E(TTM)

    33.19

  • Mar.Cap (₹Cr.)

    53,603.13

  • Div & Yield %

    2.60

  • Book Value(₹)

    2,246.68

  • Debt-Equity Ratio

    0.78

  • AGM Date

    26-Oct-2026

  • EPS

    759.85

  • P/E Ratio

    33.19

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    53,603.13

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    21.25

  • BV (₹)

    2,246.70

  • Sales( ₹ in Cr.)

    6,960.49

  • NP (in Cr.)

    1,546.80

  • NP Var(%)

    9.0

  • Div%

    6560.0

  • CPS (₹)

    763.60

  • EPS (₹)

    727.90

  • Traded Value (₹ in Lakhs)

    53,596.86

  • 52 Week High

    30,655.00

  • 52 Week Low

    24,650.00

  • Price BSE

    25222.0

  • Price NSE

    25,225.00

  • Market Capital( in Cr.)

    53,596.86

  • P/C Ratio

    33.00

  • P/E Ratio

    34.70

  • Price Vs.BV

    727.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 6,960.49 6,445.79 5,875.26 5,379.08 4,919.27 4,310.02
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 6,960.49 6,445.79 5,875.26 5,379.08 4,919.27 4,310.02
Other Income 288.14 275.58 248.27 154.15 77.21 80.90
Stock Adjustments 85.29 180.68 -7.73 -66.09 22.28 104.00
Total Income 7,333.92 6,902.05 6,115.80 5,467.14 5,018.76 4,494.92
EXPENDITURE :            
Raw Materials 3,778.11 3,677.46 3,212.88 2,908.97 2,679.49 2,494.92
Power and Fuel Cost 14.61 15.43 16.63 17.15 14.98 12.74
Employee Cost 668.82 587.54 576.58 563.59 579.46 492.65
Other Manufacturing Expenses 145.04 134.09 126.47 59.21 59.82 49.66
Selling and Administration Expenses 480.63 448.84 429.89 467.74 439.93 366.98
Miscellaneous Expenses 66.49 68.51 51.98 90.70 80.15 75.61
Employee Benefit Expenses 668.82 587.54 576.58 563.59 579.46 492.65
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5,153.70 4,931.87 4,414.43 4,107.36 3,853.83 3,492.56
Operating Profit 2,180.22 1,970.18 1,701.37 1,359.78 1,164.93 1,002.36
Interest 24.99 11.43 12.45 15.99 19.10 18.28
Gross Profit 2,155.23 1,958.75 1,688.92 1,343.79 1,145.83 984.08
Depreciation 75.96 71.80 71.17 69.97 66.10 58.13
Profit Before Tax 2,079.27 1,886.95 1,617.75 1,273.82 1,079.73 925.95
Current Tax 537.97 469.79 415.46 325.60 281.16 239.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.72 2.72 1.07 -1.19 -0.13 -3.79
Reported Net Profit 1,552.02 1,414.44 1,201.22 949.41 798.70 690.69
Extraordinary Items 5.22 -0.48 0.12 -0.19 0.00 -0.18
Adjusted Net Profit 1,546.80 1,414.92 1,201.10 949.60 798.70 690.87
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 3,220.78 2,819.01 2,428.51 2,158.40 2,023.93 1,933.54
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1,164.54 1,012.67 810.72 679.30 664.23 600.30
P & L Balance carried down 3,608.26 3,220.78 2,819.01 2,428.51 2,158.40 2,023.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 6,560.00 4,750.00 4,100.00 3,250.00 2,750.00 2,750.00
Dividend Per Share(Rs) 656.00 475.00 410.00 325.00 275.00 275.00
Earnings Per Share-Unit Curr 730.36 665.62 565.28 446.78 375.86 325.03
Earnings Per Share(Adj)-Unit Curr 730.36 665.62 565.28 446.78 375.86 325.03
Book Value 2,246.68 1,992.07 1,740.65 1,500.49 1,326.96 1,224.55
Book Value(Adj)-Unit Curr 2,246.68 1,992.07 1,740.65 1,500.49 1,326.96 1,224.55

Shareholding Pattern

  • Promoter Group

    74.99%

  • Public Share Holding

    25.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 15,934,048 74.99 15,934,048 3
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 15,934,048 74.99 15,934,048 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 3 0.00 3 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 4,624 0.02 4,574 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 84,100 0.40 84,100 57
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 264,838 1.25 264,838 14
Mutual Funds / UTI 1,604,507 7.55 1,604,457 32
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 35,930 0.17 35,930 12
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,994,002 9.38 1,993,902 120
2] Non Institution
Bodies Corporate 149,612 0.70 149,522 702
Clearing Members 300 0.00 300 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 175,101 0.82 174,718 2,061
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 76,126 0.36 76,126 1,774
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 21,242 0.10 21,242 1
Individuals holding nominal share capital up to Rs. 1 lakh 2,781,827 13.09 2,657,158 71,094
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 778 0.00 778 6
Others 116,266 0.55 116,266 2
Sub Total 3,321,252 15.63 3,196,110 75,646
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,249,302 100.00 21,124,060 75,769

Company Background

Abbott India LtdPharmaceuticals - Multinational

  • Abbott India Ltd
  • BSE Code : 90.0
  • ISIN : INE358A01014
  • Incorporation Year

    1944

  • Registered Office

    Unit No 3 Corporate Park
    Sion Trombay Road Chembur, Mumbai,
    Maharashtra-400071

  • Telephone

    91-22-67978888/50461000/2000/1119

  • FAX

    91-22-50169400

  • Chairman

    Munir Shaikh

  • Managing Director

    Kartik Rajendran

  • Company Secretary

    Sangeeta Shetty

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Abbott India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 25,222.05 7,217.19 6,929.05 33.19 43.78
Astrazeneca Phar 6,074.75 2,304.07 2,275.58 89.53 27.86
Sanofi India 2,855.65 1,857.10 1,837.40 20.31 54.17
Glaxosmi. Pharma 2,448.15 3,932.76 3,790.20 39.11 58.17
Novartis India 1,788.65 393.10 354.33 45.17 15.94
Cipla 1,353.00 20,102.60 18,979.95 35.56 13.88
Bliss GVS Pharma 617.15 773.53 729.81 57.36 12.51
Amrutanjan Healt 490.00 520.13 502.55 26.25 24.16
Fermenta Biotec. 445.65 474.15 450.25 20.81 18.77
Guj. Themis Bio. 337.75 168.25 165.82 90.31 18.05
Ambalal Sarabhai 35.99 19.52 3.94 66.65 6.77